Abstract
Biologics have become a cornerstone of modern medicine, offering groundbreaking therapies across oncology, immunology, and rare diseases. Their industrial production, however, requires mastering complex processes that combine advanced cell culture systems, bioprocess engineering, and stringent regulatory standards. This webinar will explore the key steps and challenges in the large-scale manufacturing of biopharmaceuticals—from upstream development to downstream purification.
BIOs
Gavin currently holds the position of Head of Scientific Affairs & Business Intelligence. In this role, he oversees the strategic development and implementation of scientific initiatives including MabDesign’s Watchs editions, the association’s multiple types of scientific communications and the establishment of collaborations. He also supports the various players in the industry with the implementation and development of appropriate strategies, in relation to Business Intelligence (competitive intelligence, pipeline analysis, lead generation) and Intellectual Property (patent landscape and analysis). Prior to joining MabDesign, Gavin held a number of positions in both the private and public sectors, including CRO laboratory director and university lecturer. In parallel, Gavin was a consultant to various public bodies funding research and innovation. Gavin holds a PhD in Immunology and Infectious Diseases from the University of Toulouse.
Pierre-Mehdi is part of the MabDesign team as Scientific Events Manager, where he supervises the organization of an impactful congress focused on bioprocessing. At the forefront of innovation in biopharmaceutical manufacturing and through the collaboration with leading industrial and academic stakeholders across France and Europe, the congress provides a unique vantage point on emerging trends and groundbreaking projects in the sector.
Prior to joining MabDesign, Pierre-Mehdi graduated from the University of Geneva (Switzerland) where he obtained his PhD in Biology in 2017, specialized in molecular biology and infectious diseases. He carried on his academic career as a postdoctoral fellow at the MRC Laboratory of Molecular Biology (LMB) of the University of Cambridge (UK). Through his path, he has been actively involved in the coordination of scientific events.